Pharmaceutical and Contract Research Organizations (CRO) are subjected to strict analysis regulations by their local overseeing entities (i.e. the FDA in the US).

For instance, in early drug discovery, a new chemical entity (NCE) must undergo rigorous evaluations based on the Absorption-Distribution-Metabolism-Excretion-Toxicology (ADMET) system. It is critical to determine if a NCE is a go or a no-go for further clinical trials.

Discover how our LDTD® technology dramatically increases the analytical throughput and the turnaround time for multiple applications, while attaining unequaled precision. Let us help you make important decisions faster.

If your application does not appear on the list below, please do not hesitate to contact us.

Application notes

Select the application notes and fill out the form to access the files.
The download links will appear after a few seconds.

Subscribe to our mailing list

* indicates required